A selective concentration-dependent dysrhythmogenic and antidysrhythmic action of prostaglandins E2, F2 alpha and I2 (prostacyclin) on isolated rat hearts

Experientia
M Karmazyn, N S Dhalla

Abstract

Prostaglandins (PGs) E2, F2 alpha and I2 were examined for their effects on the electrical and mechanical activities of isolated rat, rabbit and guinea-pig hearts. All PGs produced dysrhythmias in rat hearts at low concentrations only, while higher concentrations were antiarrhythmic. Guinea-pig hearts were less responsive while rabbit hearts were completely resistant.

Citations

Nov 1, 1983·Basic Research in Cardiology·U N Das
Jan 1, 1986·Toxicon : Official Journal of the International Society on Toxinology·P L BarringtonP Rosenberg
Aug 1, 1983·Prostaglandins, Leukotrienes, and Medicine·W SziegoleitW Förster
Apr 1, 1988·Prostaglandins, Leukotrienes, and Essential Fatty Acids·M C AuclairP Lechat
Nov 1, 1981·Prostaglandins and Medicine·H J Mest, W Förster
Oct 1, 1992·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·I KanzikH Zengil
May 17, 2017·Pediatric Cardiology·Safwat A AlyHoang H Nguyen

Related Concepts

Metazoa
Cardiac Arrhythmia
Dose-Response Relationship, Drug
Heart
Prostaglandins
Prostaglandins E
Prostaglandins F
Flolan
Chinchilla Rabbits
Rats, Laboratory

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.